JENBURKT PHARMACEUTICALS LTD : INTIMATION REGARDING ADMISSION OF EQUITY SHARES UNDER "PERMITTED TO TRADE" CATEGORY

• Equity shares of Jenburkt Pharmaceuticals Limited have been permitted to trade and admitted to dealings on the Capital Market Segment of NSE under the “Permitted to Trade” category. • This is effective from August 17, 2026, as per NSE Circular No. NSE/CML/75748 dated August 14, 2026. • The company clarifies it has not applied for listing of its equity shares on NSE. • Shares remain listed on BSE Limited, and availability on NSE is under the “Permitted to Trade” category. • The company became aware of the NSE circular subsequently and is making this intimation for information. Impact: Neutral (Administrative intimation regarding trading status on NSE)

Jenburkt Pharmaceuticals Ltd

Open attachment

← Back to feed